Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
149.2 USD | +0.29% | -1.44% | -4.94% |
05-07 | Tylenol maker Kenvue beats quarterly profit estimates, to cut 4% jobs | RE |
05-06 | J&J: encouraging results in prostate cancer | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.94% | 358B | |
+33.22% | 700B | |
+18.99% | 330B | |
+3.67% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.42% | 161B | |
-1.68% | 157B | |
+3.70% | 124B |
- Stock Market
- Equities
- JNJ Stock
- News Johnson & Johnson
- Goldman Sachs Adjusts Price Target for Johnson & Johnson to $181 From $163, Maintains Neutral Rating